Abstract
This work was initiated to evaluate the efficacy of post-operative adjuvant high dose rate brachytherapy(HDRB) as an alternative to post-operative adjuvant external radiation in resected T1 and T2 cancer of the oral tongue with positive or close (under 5 mm) margins. While local control and cure remained the primary objectives of treatment; minimizing the treatment morbidity, limiting the extent of surgical resection, and avoiding the complications of external beam radiotherapy to the oral cavity were our secondary objectives.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
